Summary Diabetes mellitus is a common metabolic disorder associated with chronic complications such as nephropathy, angiopathy, retinopathy and peripheral neuropathy. Diabetes is not often considered to have deleterious effects on the brain. However, long-term diabetes results in a variety of subtle cerebral disorders, which occur more frequently than is commonly believed. Diabetic cerebral disorders have been demonstrated at a neurochemical, electrophysiological, structural and cognitive level; however, the pathogenesis is still not clear. Probably alterations in cerebral blood supply and metabolic derangements play a role, as they do in the pathogenesis of diabetic neuropathy. Furthermore, the brain is also affected by recurrent episodes of hypoglycaemia and poor metabolic control. We describe herein the cerebral manifestations of diabetes and discuss the putative pathogenetic mechanisms. [Diabetologia (1994) 37: 643-650] Key woNs Diabetes mellitus, complications, brain, cerebral dysfunction, cognitive dysfunction, pathogenesis, cerebral blood flow, hypoglycaemia, hyperglycaemia, review.
nervous system are relatively subtle. Manifestations of diabetic cerebral disorders have been demonstrated at a neurochemical, electrophysiological, structural and neurobehavioural level [6] [7] . Unfortunately, only a few studies have combined measures of neurochemical, electrophysiological, structural and cognitive changes [8] [9] [10] [11] [12] [13] . In the first part of this review we describe, and provide some links between, the various cerebral manifestations of diabetes.
Various processes may lead to acute cerebral disorders in diabetic patients. Firstly, diabetic subjects have been shown to be at increased risk of cerebrovascular accidents [7, [14] [15] with a worse outcome [16] . Secondly, hyper-and hypoglycaemic episodes result in acute cerebral dysfunction [17] [18] [19] [20] . The present paper will focus on the gradually developing cerebral disorders in diabetes.
These disorders ensue from the subtle vascular, metabolic and endocrine derangements associated with diabetes. Possibly the same factors responsible for the development of peripheral neuropathy are also involved in diabetic "encephalopathy", i.e. decreased blood flow and hyperglycaemia-induced metabolic de-rangements [21] [22] . In the second part of this review changes in blood supply and metabolism in the brain will be discussed as putative pathogenetic factors in diabetic cerebral disorders.
The cerebral manifestations in diabetes

Neurochemical changes
Animalstudies. Most of our knowledge of neurochemical changes in the diabetic brain is based on results obtained with rodent models. Chemically-induced diabetes in the rat resulting from injection of either streptozotocin or alloxan, is the most frequently used animal model.
Acetylcholine release and synthesis in the striatum of streptozotocin-induced diabetic rats is decreased, although the steady-state concentration of acetylcholine is unaltered [23] , which cannot be attributed to the amount of choline available. An altered acetylcholine metabolism may contribute to the cognitive deficits exhibited in diabetes.
An increased noradrenaline content, which can be decreased by insulin administration, has been demonstrated in various regions of the diabetic rat brain [24] [25] [26] . The major noradrenaline metabolite 3-methoxy-4-hydroxyphenyl-glycosulphate is decreased indicating that diabetes decreases regional noradrenergic transmission. Chu et al. [8] suggested that the decreased adrenaline and noradrenaline content of the hypothalamus of streptozotocin-diabetic rats is involved in the observed thermoregulatory deficits as both the altered monoamine content and the impaired thermoregulation can be reversed by insulin therapy.
Serotonin turnover is decreased, as evidenced by decreased levels of the serotonin metabolite 5-hydroxyindoleacetic acid in several brain regions in diabetic rats [25] [26] [27] . A decreased serotonin turnover in the hypothalamus may represent compensation for the disrupted control of feeding behaviour caused by lack of circulating insulin [25] . Dopaminergic neuronal activity is decreased and dopamine content is increased in the diabetic brain [8, [25] [26] [27] . Furthermore, changes in dopamine receptors in the striatum of diabetic rats have been reported. The Dl-receptor density in the striatum is decreased [28] , however, D2-receptor density is increased [29] which is considered to represent a compensatory adjustment to the reduction in central dopaminergic neuronal activity. Another putative explanation is that altered D1-and D2-receptor densities are related to Gprotein function. Activation of D1-and D2-receptors is known to involve Gs and Gi proteins, respectively. As Gi protein function is impaired in the striatum of diabetic rats [30] the altered receptor densities could represent a compensatory mechanism for alterations in G protein function [28] .
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Human studies. An increased serotonin turnover has been demonstrated in the brain and cerebrospinal fluid of diabetic patients in severe ketoacidosis [31] . Since ketoacidosis itself may lead to neurochemical alterations quite beyond the effects routinely found in diabetes, these data should be interpreted with caution. Lackovic et al. [26] demonstrated an increased serotonin content in the medial and lateral hypothalamus in post-mortem brain samples from diabetic patients. The dopamine content was increased in the medial hypothalamus, putamen, and medial and lateral parts of the pallidus. None of the patients in this study had a record of neurological, psychiatric, or endocrine disease. Therefore, the observed neurochemical alterations were attributed to diabetes.
In summary, neurochemical alterations in the brain are evident in both human and experimental diabetes. An altered monoaminergic function may increase the risk for development of, for instance, major affective disorders [9, [32] [33] [34] . Short-term insulin withdrawal readily induces neurochemical changes in the brain, and insulin replacement leads to complete or partial restoration of these alterations. A possible consequence of exogenously administered insulin would be alternating extremes of monoamine turnover: a reduction during hyperglycaemia and an increase during hypoglycaemia [27] .
The relevance of the neurochemical findings in chronically hyperglycaemic rodent models can be questioned, since virtually all diabetic patients are treated with either insulin or oral hypoglycaemic drugs [31] . Other rodent models of diabetes, such as the insulin-dependent spontaneous diabetic BB/Wor rat, could provide valuable new insights into cerebral function in diabetes.
Electrophysiological abnormalities
Animal studies. BB/Wor rats demonstrate progressive prolongation of visual evoked potential latencies after 6 and 12 months of diabetes [35] [36] . These electrophysiological abnormalities could, partly, be due to the accompanying axonal atrophy of the optic nerve. Abnormalities of second order neurons and their projections to the visual cortex could also contribute to the impaired impulse propagation. The alterations in the diabetic optic nerve, although more subtle, appear to be similar to those described in peripheral nerves in this animal model which suggests a common underlying pathogenetic mechanism.
Human studies. In elderly NIDDM patients, slowing of the EEG rhythm occurs over the central cortex [10] . These changes could not be reproduced by induction of acute hyperglycaemia in healthy volunteers [10] . Nonspecific EEG abnormalities have been reported in 19 to 76 % of diabetic children in contrast to 10 to 15 % of healthy children [11] . Metabolic control, frequent and severe hypoglycaemic attacks, and vascular changes in the retina are correlated with EEG abnormalities. In children with good, insufficient or poor metabolic control, the frequency of EEG abnormalities was 7%, 22 % and 60 %, respectively [11] .
Brain stem auditory evoked potentials, visual evoked potentials and somatosensory evoked potentials represent non-invasive procedures for monitoring central nervous system involvement in diabetes [37] [38] [39] . Evoked potentials involve artificial stimulation of sensory pathways in order to reveal disturbances in both central and peripheral conduction. Several studies report abnormalities in short-latency evoked potentials of both central and peripheral origin in both IDDM and NIDDM patients [12, 38, [40] [41] . Central conduction velocities are slowed within 2 years after diabetes onset [12, 37] . These early conduction abnormalities appear to be correlated with the degree of metabolic control [37] .
In addition to increased brainstem auditory, visual evoked, and somatosensory evoked potentials latencies an overall increase in the P300 wave latency has been demonstrated in IDDM patients [13] . The P300 wave is a late cortical neurophysiological event associated with cognitive and mnemonic functions in humans [4243] and is considered to reflect the speed of neuronal events underlying information processing and appears to be strongly associated with attention and short-term memory [42] [43] [44] . An increased P300 latency may be a manifestation of significant impairment of higher brain functions in diabetes [13] , and could thus provide a link between the electrophysiological and neurobehavioural abnormalities.
Structural changes
Animalstudies. An ultrastructural study of the cortex of diabetic hamsters revealed vascular lesions, mitochondrial abnormalities in neurite processes, axonal degeneration and loss of neurons [45] . This diffuse structural damage in the brain in long-term, experimental diabetes has been confirmed in diabetic rats [46] , where mild neuronal degeneration, especially in the brain stem, and astrogliosis were demonstrated by light and electron microscopy. Quantitative studies on changes in the cerebral neocortex of insulin-treated, long-term diabetic rats demonstrated reduction in brain size and, more specifically, reduction in neocortical size associated with a direct loss of neocortical neurons. The finding of neuronal loss suggests that atrophy is at least partially responsible for the reduction of brain size. Furthermore, diabetes disproportionately reduces the density of the neocortical capillary network and causes thickening of capillary basement membranes [47-48] which could contribute to the development of diabetic cerebral disorders.
Human studies. Fibrosis of the meninges, angiopathy, pseudocalcinosis and severe diffuse degeneration of white and grey matter have been described in a neuropathology study of 16 young long-term IDDM patients [49] . It was assumed that the abnormalities observed in the brains of these patients were the result of diabetes and justified the term "diabetic encephalopathy". However, one should consider that the 16 patients selected for this study presented with widespread vascular disease and retinopathy, 14 showed signs or symptoms of nervous disease and 8 had mental disturbances. The existence of diabetic encephalopathy was substantiated recently by the demonstration of abnormal plaques in magnetic resonance-scans in 69 % of a group of diabetic patients [12] ; comparable lesions were observed in only 12 % of an age-matched control group. The lesions observed may represent demyelination, an increased water content or gliosis.
Neurobehavioural disorders
Diabetic patients have been shown to perform worse than control subjects in a wide range of cognitive tests. Problems with memory and learning, problem solving and mental and motor speed have been noted [10, [50] [51] [52] [53] [54] [55] [56] . In general, diabetic patients show small but detectable reductions in cognitive function more frequently than is commonly assumed. The majority of differences between healthy and diabetic subjects are not likely to be seen for types of motor function that do not involve complex decisions before responding [57] . Therefore, these deficits appear to have a limited effect on routine day-to-day functioning [52, 55] .
There has been little agreement between studies regarding the specific tasks impaired in diabetic patients, and the magnitude of the impairment [55] . The heterogeneity of the populations involved may be part of the reason: some studies concern children and adolescents, some adults, some IDDM and some NIDDM.
Identification of possible risk factors may make prevention of cognitive disorders in diabetes possible. The difficulties in assessing these risk factors have been reviewed by Ryan [52] . Studies of risk factors for cognitive dysfunction in diabetic children have focused on four variables: age at diabetes onset, disease duration, metabolic control and the number of clinically significant hypoglycaemic episodes. Age at onset is strongly related with IQ scores [58] [59] [60] . Children who develop diabetes before 5 years of age learn new information less efficiently and score lower on tasks of general intelligence than their non-diabetic siblings. In children who develop diabetes after 5 years of age no such impairment is seen. The disease duration affects performance in only a small subset of tests; namely, those measuring school achievement and verbal intelligence [59] . Poor performance could be attributed to increased absenteeism from school [52] ; however, it has been shown that this does not account fully for the cognitive deficits observed in diabetic children [61] [62] .
Inadequate glycaemic control, as determined by HbA1 values, is related to cerebral dysfunction in children as do severe hypoglycaemic episodes [60] . It has recently been demonstrated that visual and spatial abilities are correlated with even asymptomatic recurrent hypoglycaemia [62] .
The correlation between early diabetes onset and cognitive impairment can be explained by two phenomena. Firstly, children who develop diabetes early experience more hypoglycaemic episodes than children who develop it later. This can be attributed to a heightened sensitivity to insulin, a lower dietary compliance and a poorer communication of hypoglycaemic symptoms in young children [60] . Secondly, the brains of young children are very sensitive to the effects of virtually any abnormal metabolic or electrophysiological event making it more likely that severe hypoglycaemic episodes have deleterious effects when they occur early in life [52] .
Prevention of diabetic complications has been attributed to intensified insulin treatment. However, this increases the frequency of hypoglycaemia [6344] , and may thus adversely affect the brain. The frequency of severe hypoglycaemic episodes is inversely correlated with IQ and measures of inspection time and reaction time in adult IDDM patients [52, 56, [65] [66] . Although a correlation between cognitive function and hypoglycaemic episodes has been repeatedly demonstrated, two recent studies failed to show such an effect [54, 63] . However, the evidence in favour of a correlation between cognitive function and hypoglycaemia seems convincing.
Poor glycaemic control has been shown to impair cognitive function in NIDDM [52] [53] [54] 57] . Subjects with increased HbA1 levels tend to perform more poorly on learning, reasoning and complex psychomotor tasks. Poor glycaemic control contributes to other longterm diabetic complications such as retinopathy and peripheral neuropathy. It has recently been suggested that the primary predictor of diabetic neurobehavioural dysfunction is the development of other clinically significant diabetic complications [54] . Patients with mild to moderate retinopathy show mild impairment on tests requiring complex problem solving and abstract reasoning skills [67] . Furthermore, definite distal symmetrical neuropathy is associated with a lower level of cognitive performance, particularly on psychomotor tasks. A tentative explanation is that the same pathogenetic mechanisms are involved in central and peripheral neuropathy [53] .
We have mentioned that altered monoaminergic function in diabetes may predispose patients to major affective disorders [9, [32] [33] [34] 68 ]. An increased prevalence of psychiatric disorders, in particular depressive and anxiety disorders, has been reported in both IDDM and NIDDM [32-34, 51, 69-70] . The com-G. J. Biesseis et al.: Cerebral function in diabetes posite estimate for the prevalence of active depression in 11 uncontrolled studies (five IDDM, three NIDDM three mixed or non-specified) was 18 % [33] . Although depressive symptoms are more common in the medically ill in general, there appears to be an increased incidence in diabetic patients [32] [33] . The reliability and validity of psychiatric diagnoses in the medically ill have been questioned, since some of the criterion symptoms for psychiatric diagnoses are also symptoms of unstable diabetes [33, 71] . However, Lustman et al. [72] found that exclusion of somatic symptoms from diagnostic criteria had little effect on the observed prevalence of major depression and dysthymic disorder in diabetes.
The significance of clinical depression in diabetes should not be underestimated. Depression is a debilitating disorder that typically impairs all aspects of an individual's functioning [32] [33] 51] . Cognitive deficits and psychiatric disorders could even interfere with treatment compliance and thus impair glycaemic control. The cause of the increased prevalence of depression in diabetes remains unclear. Depression may result from an inability to cope with the stresses of diabetes, but may also result from direct effects of diabetes on the central nervous system, or a combination of both [33, 51, 69] .
Pathogenetic mechanisms
The manifestations of diabetic cerebral disorders, described earlier in this review, are diverse and several processes play a role in their pathogenesis. The presence of cerebral disorders in both IDDM and NIDDM is intriguing. Factors other than the pathogenetic mechanisms differentiating both types of diabetes appear to play a major role.
Vascular disorders. Thickening of capillary basement membranes, the hallmark of diabetic microangiopathy, has been demonstrated in the brain of diabetic humans and animals [47, 48, 73] . In addition to morphological changes in the cerebral vaculature, alterations in CBF and vascular reactivity have been reported. Decreased CBF has been described in both acutely and chronically hyperglycaemic animals [74] [75] . The relationship between the degree of hyperglycaemia and CBF is linear and the decrease in CBF shows a regional distribution. The presence of a regional variation in reduction of CBF suggests that other factors besides systemic effects induced by glucose, such as hyperosmolarity or hyperviscosity, mediate the reduction in flow. Whether a decreased brain capillary density is involved in reduced CBF remains to be determined, since reports on this issue are contradictory [47, 76] . A decreased CBF might be implicated in the pathological changes of the diabetic brain, similarly to decreased nerve blood flow in the pathogenesis of periph-eral diabetic neuropathy [21] . It is not certain whether good-to-moderate glycaemic control in diabetic patients produces similar alterations in CBF as it does in animal models. Decreases in basal CBF have been reported in IDDM [7] , and changes in CBF correlate inversely with diabetes duration [77] . However, in one study of normoglycaemic IDDM subjects CBF was actually found to be increased, particularly in the cortex. A striking finding was the resemblance of the pattern of regional CBF in the IDDM patients to that in patients with attention deficit disorders [78] .
Cerebrovascular reactivity is impaired in long-term diabetic patients and animals [79] [80] [81] [82] . Sympathetic dysfunction (e. g., reduced circulating catecholamines and diminished cerebral fl-adrenoceptor sensitivity) and increased stimulation of the thromboxane Aa-PGH2 receptor have been implicated [81] [82] . Cerebral vasoreactivity, and accompanying changes in CBF, during hypoglycaemia, hypotension, hypoxia and hypercapnia are important compensatory mechanisms. A blunting of the cerebral hyperaemic response to hypoglycaemia, leading to functional impairment in the CNS, has been reported in chronically diabetic rats [82] . Therefore, diabetic patients might be at greater risk of hypoglycaemia-induced central nervous system impairments than non-diabetic subjects. Recent evidence suggests that during hypoglycaemia neuropsychological impairment is more pronounced in diabetic than in control subjects with the same blood glucose level [83] .
Metabolic disorders. Tight control of blood glucose levels in insulin treated diabetic patients imposes a major risk: overdosage of insulin may result in severe hypoglycaemia which acutely impairs cognitive functioning [19-20, 54, 84-85] . The awareness of hypoglycaemia which is caused by activation of the autonomic nervous system, diminishes with increased duration of diabetes and with strict glycaemic control [19] . Hypoglycaemic episodes themselves may be implicated in the development of this unawareness and associated impairment of the sympathoadrenal response [19] [20] . Cognitive changes that accompany a single hypoglycaemic episode are usually considered to be transient because neurobehavioural test performance returns to pre-hypoglycaemic baseline levels with restoration of normoglycaemia [54] . However, repeated episodes of hypoglycaemia have been shown to be a major cause of permanent cognitive impairment [50, 52, 56, [65] [66] and may cause cumulative damage to the brain. This process may be analogous to the progressive deterioration of intellectual function which is demonstrable following chronic exposure to various insults such as hypoxia induced by sleep apnoea or trauma from recurrent head injury [66] .
In rats, the EEG slows as the blood glucose level falls to the range of 2.0-2.5 mmol/1 [86] . Neuronal necrosis does not ensue until the EEG has been isoelec-tric for at least several minutes, the extent of neuronal necrosis being related to the duration of cerebral isoelectricity [87] . These findings suggest that energy failure and loss of ion homeostatis are associated with cessation of EEG activity, and may trigger the deleterious events leading to neuronal damage [88] . Selective necrosis of neurons during hypoglycaemia, sparing astrocytes and oligodendrocytes, has been shown to result from overactivation of a subtype of excitatory amino acid receptor, the NMDA-receptor. NMDA-receptor overactivation leads to pathologically enhanced levels of free intracellular calcium [89] [90] , in turn leading to loss of nuclear and mitochondrial function and activation of proteases and other calcium-dependent enzymes [90] [91] [92] . The distribution of hypoglycaemiainduced neuronal necrosis within the brain, with early damage in the cerebral cortex, striatum and hippocampus [86] , correlates with NMDA-receptor density [93] . NMDA antagonists have been shown to prevent been shown to prevent neuronal necrosis in hypoglycaemia [88, 94] . The role of excitatory amino acids in hypoglycaemia-induced acute brain damage imposes the possibility of pharmacotherapeutic intervention [95] .
The brain handles glucose and other nutrients differently in diabetes [7] , and transport of glucose, electrolytes and amino acids into the brain is altered [96] [97] [98] [99] . However, reports about brain glucose metabolism are not equivocal. Several studies reported a reduced brain glucose uptake in chronicly hyperglycaemic rats [7, 96 , 100] which has been attributed to diminished concentrations of glucose transporters at the blood-brain barrier [100], although this has not been confirmed by some studies [75] [76] . In humans, major changes in glucose uptake across the blood-brain barrier apparently do not occur, except in extreme hypo-or hyperglycaemia [101] . Although glucose uptake is not affected in the brain of diabetic patients, glucose metabolism may be altered and has been reported to be increased [78] .
In diabetic patients and animals the ratio of brain to blood glucose concentrations is increased [18, 102, 103] . This implies that even in normoglycaemia the central nervous system of diabetic subjects is exposed to increased glucose concentrations. Hyperglycaemia-induced metabolic derangements are implicated in the pathogenesis of peripheral diabetic neuropathy [22] . In the peripheral nervous system, hyperglycaemia-induced nerve myo-inositol depletion is thought to reduce Na,K-ATPase activity, leading to nerve dysfunction [1] . Decreased Na,K-ATPase activity has been demonstrated in the central nervous system of streptozotocin-diabetic rats [104] and shows regional variation, with the decrease being most pronounced in the cerebral cortex and hippocampus. However, chronically elevated glucose levels do not appear to reduce the brain myo-inositol content, in fact in diabetes it appears to be increased [18, 97] . The link between myoinositol depletion and Na,K-ATPase activity in the central nervous system is therefore questionable.
In summary, central nervous system and peripheral nervous system metabolism are altered differently in diabetes. The role of the cerebral metabolic changes in the pathogenesis of diabetic cerebral disorders remains to be elucidated.
Conclusions and clinical implications
Long-term diabetes can result in a variety of subtle cerebral disorders which occur more frequently than is commonly believed. Manifestations of these disorders include alterations in neurotransmission, electrophysiological abnormalities, structural changes and neurobehavioural alterations. The effect of cerebral dysfunction on the daily functioning of diabetic patients appears to be limited. Although this is comforting, it should be considered that there is only limited knowledge into the exact magnitude of the impact of diabetes on the brain, especially in the long term. Most diabetic cerebral disorders are not routinely screened for in clinical practice. However, the clinician should be aware of affective disorders occurring in diabetic patients which may interact with diabetes at several levels. Moreover, drug treatment of these disorders may improve both mood and glycaemic control in diabetes.
Clinically, glycaemic control appears to be the most important factor in preventing diabetic cerebral disorders, still it plays a dual role. On the one hand, chronic hyperglycaemia has a long-term deleterious effect on the brain. Cognitive performance deteriorates and cerebral neurochemistry, metabolism and vasculature are altered. Attainment of normoglycaemia could prevent these phenomena. On the other hand, the risks associated with the achievement of near normoglycaemia are considerable. The occurrence of frequent hypoglycaemic episodes is a major risk factor in the development of cognitive impairment in diabetes. The level of glycaemic control which has the lowest impact on the brain in the long term remains to be determined.
In the clinical and experimental approach to diabetes attention must be paid to the effect of diabetes on the central nervous system. Clinical and animal studies are required to increase insight into the magnitude and the pathogenesis of diabetic cerebral disorders.
